Value in Health

ISSNs: 1098-3015

Additional searchable ISSN (Electronic): 1524-4733

Elsevier Inc.

Scopus rating (2018): CiteScore 3.46 SJR 1.836 SNIP 1.67

Journal

Publications

  1. 2019
  2. Analytic considerations in applying a general economic evaluation reference case to gene therapy

    Drummond, M. F., Neumann, P., Sullivan, S., Fricke, F. U., Tunis, S., Dabbous, O. & Toumi, M., 12 Jun 2019

    Article in Value in Health

  3. Real-World Evidence in Healthcare Decision Making: Global trends and case studies from Latin America

    Justo, N., Espinoza, M., Ratto, B., Nicholson, M., Rosselli, D., Ovcinnikova, O., García Martí, S., Ferraz, M. B., Langsam, M. & Drummond, M. F., 12 Jun 2019

    Article in Value in Health

  4. Multi-criteria decision analysis to support HTA agencies – benefits, limitations and the way forward

    Baltussen, R., Marsh, K., Thokala, P., Diaby, V., Cleemput, I., Garau, M., Iskrov, G., Olyaeemanesh, A., Mirelman, A., Mobinizadeh, M., Morton, A., Tringali, M., van Til, J., Valentim, J., Wagner, M., Youngkong, S., Zah, V., Toll, A., Jansen, M., Bijlmakers, M. J. & 2 othersOortwijn, W. & Broekhuizen, B., 5 Jun 2019, (Accepted/In press)

    Article in Value in Health

  5. Identifying the need for good practices in Health Technology Assessment: summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA

    Kristensen, F. B., Husereau, D., Huic, M., Drummond, M. F., Berger, M., Bond, K., Augustovski, F., Booth, A., Bridges, J. F. P., Grimshaw, J., Ijzerman, M. J., Jonsson, E., Ollendorf, D., Ruther, A., Siebert, M., Sharma, J. & Wailoo, A., Jan 2019

    Article in Value in Health

  6. 2018
  7. Economic analysis of vaccination programs

    Mauskopf, J., Standaert, B., Connolly, M. P., Culyer, A. J., Garrison, L. P., Hutubessy, R., Jit, M., Pitman, R., Revill, P. & Severens, J. L., 1 Oct 2018

    Article in Value in Health

  8. The use of MCDA in HTA: great potential, but more effort needed

    Marsh, K., Sculpher, M. J., Caro, J. J. & Tervonen, T., 26 Apr 2018

    Article in Value in Health

  9. A Health Economics Approach to US Value Assessment Frameworks - Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Garrison, L. R., Neumann, P., Willke, R., Basu, A., Danzon, P., Doshi, J., Drummond, M. F., Lakdawalla, D., Pauly, M., Phelps, C., Ramsey, S., Towse, A. & Weinstein, M., 23 Feb 2018

    Article in Value in Health

  10. 2017
  11. ISPOR Code of Ethics 2017 (4th Edition)

    Santos, J., Palumbo, F., Molsen-David, E., Willke, R. J., Binder, L., Drummond, M., Ho, A., Marder, W. D., Parmenter, L., Sandhu, G., Shafie, A. A. & Thompson, D., 1 Dec 2017

    Article in Value in Health

  12. UK Utility Elicitation in Patients with Follicular Lymphoma

    Wang, H., Smith, A., Yu, G., Aas, E., Bagguley, T., Howell, D., Roman, E., Burton, C. & Patmore, R., 20 Oct 2017

    Article in Value in Health

  13. Comparing Increments in Utility of Health: An Individual-based Approach

    Taylor, M., Chilton, S., Ronaldson, S., Metcalf, H. & Nielsen, J. S., 24 Feb 2017

    Article in Value in Health

  14. 2016
  15. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought

    Wilkinson, T., Sculpher, M. J., Claxton, K., Revill, P., Briggs, A., Cairns, J. A., Teerawattananon, Y., Asfaw, E., Lopert, R., Culyer, A. J. & Walker, D. G., Dec 2016

    Article in Value in Health

  16. 2015
  17. CE2 - A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease

    Bryden, P., Welton, N. J., Thom, H., Sterne, J. A. C., Bodalia, P., Davies, P., López-López, J. A., Okoli, G. N., Caldwell, D. M., Dias, S., Eaton, D., Higgins, J., Salisbury, C., Savovic, J., Sofat, R., Stephens-Boal, A., Hingorani, A. & Hollingworth, W., Nov 2015

    Article in Value in Health

  18. Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation

    Lopez-Lopez, J. A., Sterne, J., Bodalia, P. N., Bryden, P. A., Davies, P., Okoli, G. N., Thom, H., Caldwell, D. M., Dias, S., Eaton, D., Higgins, J., Hollingworth, W., Salisbury, C., Savovic, J., Sofat, R., Stephens-Boal, A., Welton, N. J. & Hingorani, A., Nov 2015

    Meeting abstract in Value in Health

  19. PCV103 - The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

    Thom, H. H. Z., Hollingworth, W., Bryden, P. A., Sterne, J., Bodalia, P. N., Davies, P., Lopez-Lopez, J. A., Okoli, G. N., Caldwell, D. M., Dias, S., Eaton, D., Higgins, J., Salisbury, C., Savovic, J., Sofat, R., Stephens-Boal, A., Hingorani, A. & Welton, N. J., Nov 2015

    Meeting abstract in Value in Health

  20. PCV95 - A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease

    Bryden, P., Welton, N. J., Thom, H. H. Z., Sterne, J. A. C., Bodalia, P., Davies, P., López-López, J. A., Okoli, G. N., Caldwell, D. M., Dias, S., Eaton, D., Higgins, J., Salisbury, C., Savovic, J., Sofat, R., Stephens-Boal, A., Hingorani, A. & Hollingworth, W., Nov 2015

    Article in Value in Health

Previous 1 2 3 4 5 Next

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations